NIST GCR
02-830
Measuring the Impact of ATP-Funded Research Consortia on Research Productivity
of Participating Firms
A Framework Using
Both U.S. and Japanese Data
Chapter
4. EFFECTS OF CONSORTIUM CHARACTERISTICS ON CONSORTIUM PERFORMANCE
METHODOLOGY
The methodology presented
in the previous section examines the impact of consortia participating
on overall patenting. It does not, however, allow us to answer two
important questions: (1) What is the impact of participation on the
collective patenting of participating firms in the technological
areas targeted by the consortia? (2) What kinds of consortia are
most successful at promoting research productivity of participating
firms?
To answer these questions,
we need to measure the impact of consortium participation on patenting
outcomes in the technological areas targeted by the research consortia, and
compare the outcomes of different consortia projects.
The methodology used
in this section and the subsequent one draws heavily from Branstetter
and Sakakibara (2000). Below we define our dependent variable and
discuss its strengths and weaknesses. Next, we discuss the independent
variables used in this analysis. Then, we present our basic estimating
equations followed by our results.
DEPENDENT VARIABLE
Innovative output,
our dependent variable, is a measure of patenting by consortia participants
in the technological areas targeted by the consortia.1 We
mapped the technological goals of ATP projects to their corresponding
patent classes in order to create our dependent variable. The USPTO
assigns each patent to a patent class that categorizes the technology.
After assigning the stated technological objectives of an ATP-funded
research consortium to the appropriate patent class or classes, we
counted the number of patents taken out by participating firms in
the targeted technologies before, during, and after the projects.
This provided a panel dimension to the data on research outcomes.
Creating this mapping
from ATP project technological goals to patent classes was not easy
because of the complexity of the USPTO classification system and
the broad range of technologies targeted by different ATP projects.
We relied on the expertise of outside consultants to create this
mapping.2
To the extent that
our mapping is imprecise, we measure patenting in the targeted areas
with error. The mapping we constructed likely includes more patents
than are, in reality, directly connected technologically to the goals
of the ATP project. The imputed level of patenting in the targeted
area may overstate the impact of the project on firm patenting; however,
the behavior of this variable over time within a project should be
an accurate measure of impact.
INDEPENDENT VARIABLES
Time path of
benefits. If a consortium had a significant impact
on participating firms innovative performance, we should
be able to observe a consortium-induced upturn in the patenting
of participating firms in the targeted area. Did the consortium
boost to patenting merely occur during the first few
years of the project, or do we observe a lasting impact on
the level of patenting in the targeted area? Obviously, the time
path of benefits from consortium participation is of
interest. The time path was traced in two ways and is explained
more fully under Model below.
Pre-project patenting
in the targeted class. Measuring the impact of a
consortium requires that we control for the patenting of
participating firms in the targeted areas prior to the start
of the project.
Project budgets. We
control for the total public and private resources channeled into
consortia research. We have information on the total budget of each
project and the governments share. In the panel regressions,
we divide the total budget by the number of years in which this budget
was active in order to create an annualized budget series. All R&D
numbers are adjusted for inflation.
Technological
proximity of participants. The strongest potential
for R&D spillovers may exist among firms that pursue
research in the same technological areas.3
To measure proximity
of firms in technology space, we followed the framework developed
by Jaffe. A firms R&D program may be described by the vector F,
where Fi=(f1
fk) and
each of the k elements of F represents the firms
research resources and expertise in the kth technological
area. This is measured by the number of patents held by a firm in
a narrowly defined technological field. We measure the technological
proximity between two firms by measuring the degree of similarity
in their patent portfolios. More precisely, the distance in
technology space between two firms i and j is approximated
by Tij where Tij is the uncentered correlation
coefficient of the F vectors of the two firms, or
(2)
We calculated average
Tij measures for each project for which we had sufficient
data.
Resources from
overlapping consortia. Some firms participated in
multiple consortia and some consortia tended to target similar
classes of technologies. Therefore, simply looking at the
output of a project while controlling only for the inputs
participating firms received as a function of their participation
in that project may understate the total resources being
devoted to research in a particular class of technologies.
We used information on the overlap in projects, both in terms
of participating firms and targeted classes, to impute the
variable indirect inputs. 4
Firms perceptions
of consortia impact. ATPs Business Reporting
System (BRS)5 provides information on firms perceptions
of the impact of consortia participation on research outcomes.
Using responses to the survey questions listed below, we
address the following question: Are positive perceptions
of value correlated with empirical measures of research outcomes?
- Stimulate_creative_thinkingTo
what extent has collaboration enabled your firm to stimulate
creative thinking? Here, and in most cases below, firms were
asked to give an ordinal response, i.e., significantly, moderately, little/none, or unsure.
- Avoid_redundant_R&DTo
what extent has collaboration enabled your firm to avoid redundant
R&D expenses?
- R&D_cost_savingHow
much (in dollars) has your company saved in R&D expenses
through collaboration?
- Time_savingTo
what extent has collaboration allowed your company to save time
in general?
- Delayed_product_entryTo
what extent has collaboration delayed product entry into the
marketplace?
- Delayed_R&D_phaseTo
what extent has collaboration contributed to a delay in the R&D
phase?
To protect the confidentiality
of firms responses, ATP disguised firm identity in these data.
As a result, we averaged firm-level responses by consortium and linked
this averaged response to other data.
The firms responses
came from different ATP reports; some came from the closeout report,
others came from reports during the operation of the project. The relative
success or failure of a consortium may affect a managers perceptions
of the consortiums attributes; thus, these qualitative data are
not necessarily exogenous, in a statistical sense, to our measures of
project outcomes. Nevertheless, we present our regressions as a way of
assessing statistical relationships between these variables and research
outcomes, without necessarily being able to prove anything about the
causal nature of the relationship.
MODEL
The
basic empirical model used in this section is as follows:
(3)
Here Pit denotes
the sum of U.S. patent grants generated by member firms of consortium i in
year t in the technological areas targeted by the consortium.
Pit is given as a simple count. Budgetit represents
the total research resources expended by the consortium. Pre_project_patentingi denotes
the average patenting in the targeted classes, with the average taken
over a 5-year window prior to the official start date of the project.
Our qualitative variables are represented in the sigma term.
The spillover-inducing
effect of the consortia is captured with a method borrowed from the macroeconomics
literature on impulse response function.6 A skeptical view
of the benefits of research consortia maintains that any positive impact
on the innovative output of participating firms is produced entirely
by the combination of subsidies granted to the participants and the research
resources expended by the participating firms out of their own R&D
budgets. A positive view of the benefits of research consortia maintains
that, in addition to the public and private financial resources expended,
the process of bringing firms with complementary research assets into
contact should itself enhance the innovative activity of the firms involved.
Project_durationit is
a dummy variable set equal to one during the years, t, for which
project i is active. The regression coefficient on project_durationit measures
the boost to patenting in the targeted area sustained by the participating
firms during the duration of the project. If this variable is
positive and significant, then we interpret this as evidence that participation
in consortia promotes spillovers of complementary knowledge among participants,
enhancing the productivity of their collective research effort, and that
these effects generate a more or less immediate impact on the patenting
of consortium members.
Presumably, a boost to
patenting in the targeted area that endures past the conclusion of the
project is of greater social value than one that ends with the project.
To get a sense of the average time path of benefits, we constructed two
additional variables: years_passedit and years_passed2it.
Years_passedit measures the years elapsed since the start of a given
project. A positive coefficient on years_passedit and
a negative coefficient on years_passed2it imply that the boost
to patenting has a quadratic shape: it rises initially after the start
of the project, but peaks and then declines at some later date.7 A
large, positive coefficient on years_passedit and a
relatively small, negative coefficient on years_passed2it would
imply that a relatively long-lasting boost is obtained from consortia
participation.
Another way to estimate
the time path of benefits is to include a number of dummy variables corresponding
to periods of set length after the inception of a project, and to examine
the coefficients on these various dummies. This more flexible approach
does not impose a quadratic structure on the benefits stream. Due to
the time-truncation problem in our U.S. data, we are only able to estimate
lags up to four years in length.
RESULTS
In our initial regression,
we estimate the stripped down version of equation (3), leaving
out, for the moment, our qualitative data on the nature of the consortia.
Results are given in column 1 of Table 3. A Poisson regression model
is used to explicitly allow for the count data characteristics
of the dependent variable. The coefficient on project_duration has
the interpretation of the additional patents generated per year that
a consortium is in operation. In column 1, the coefficient on project_duration is
positive and significant, though rather small in magnitude.8
The coefficient on budget is
negative and significant, suggesting that a larger budget for a consortium
paradoxically results in fewer patents. We believe this to be an artifact
of the data, driven by trends in ATPs budget. When ATP began sponsoring
its first projects during the first Bush Administration, it had a modest
budget. The ATP considerably expanded during the Clinton Administration;
however, our patent coverage for these later years is truncated. The
negative coefficient for budget, which appears in most of our
succeeding specifications, is probably driven by truncation of patents
resulting from later projects rather than strongly decreasing returns
to R&D subsidies.
The coefficient on years_passed is
positive and significant, and the coefficient on years_passed2 is
negative and significant. These coefficients imply a boost to patenting
that is small initially, grows fairly rapidly, peaks within 23
years of the inception of a project, and declines thereafter. Our interpretation
of the coefficients on project_duration, years_passed,
and years_passed2 are all clouded by the time truncation
problem in our patent data. With a longer post-project time series, we
may very well observe more long-lived effects.
In column 2, we implement
a more flexible version of the impulse response function, using dummy
variables to represent time lags instead of the quadratic form used in
column 1. The results of this model are quite consistent with the results
of the quadratic time path of benefits estimated. The impact of participation
in the first year is small and not statistically significant. Thereafter,
the measured impact grows rapidly, peaking in the second year, and declining
rapidly thereafter. Because of the time truncation in our data, the actual
decline may be less rapid than the apparent decline shown in this model.
This concern notwithstanding, these results support the evidence presented
in the previous section: participation in ATP-funded consortia has
a positive, statistically significant impact on patenting by participating
firms in the targeted technology.
Column 3 adds our measure
of average technological proximity to our baseline specification. Column
4 adds calendar year as a control variable to capture any overall time
trend in patenting. In both cases, higher measured technological proximity
is positively and significantly associated with higher levels of patenting
in the targeted technologies. This suggests that the measure of average
proximity we constructed here can be used to help predict the likelihood
of project success ex ante.
Table
3. Consortium-Level Analysis
Poisson regression
Dependent variable:
Sum of patent grants by consortium participants in the targeted area
| Variables |
(1) |
(2) |
(3) |
(4) |
(5) |
| Budget |
-7.08e-08
(1.44e-09) |
-7.09e-08
(1.44e-09) |
-6.88e-08
(1.46e-09) |
-6.88e-08
(1.51e-09) |
-6.71e-08
(1.45e-09) |
| Pre-project
patenting |
.004
(.0000104) |
.004
(.0000104) |
.003
(.0000114) |
.003
(.0000116) |
.004
(.0000106) |
| Project
duration dummy |
.054
(.012) |
|
.046
(.013) |
.319
(.015) |
|
| Years passed |
.431
(.018) |
|
.445
(.019) |
.452
(.018) |
|
| Years passed2 |
-.104
(.005) |
|
-.111
(.005) |
-.101
(.005) |
|
Year 0 dummy(a)
(.013) |
|
.019
|
(.014) |
|
.258
|
| Year 1 dummy |
|
.383
(.016) |
|
|
.573
(.016) |
| Year 2 dummy |
|
.558
(.017) |
|
|
.659
(.017) |
| Year 3 dummy |
|
.283
(.02) |
|
|
.716
(.022) |
| Year 4 dummy |
|
.254
(.033) |
|
|
.510
(.033) |
| Average
technological proximity |
|
|
.343
(.019) |
.091
(.020) |
|
| Calendar
year |
|
|
|
.096
(.002) |
|
| Real indirect
inputs |
|
|
|
|
-1.18e-07
(3.41e-09) |
| Constant |
3.72
(.008) |
3.72
(.008) |
3.90
(.011) |
194.341
(.618) |
3.66
(.008) |
| R-squared |
.7726 |
.7730 |
.8062 |
.8192 |
.7808 |
Note:
Standard errors in parentheses. The R-squared measure for the Poisson regression
given here is a pseudo-R-squared measure.
(a) Year 0 indicates the year of the inception of a consortium.
We test the robustness
of our baseline specification by including indirect resources received
by project participants from other overlapping projects. Results
are given in column 5. The basic results of our regression are
unaffected by including this additional control variable.
Lastly, we include
firms responses to survey questions in the BRS while controlling
for project budget and pre_project_patenting in the
targeted area. Results presented in Table 4 are grouped by survey
content. The model in column 1 shows that the coefficient on stimulate_creative_thinking is
positively and significantly associated with patenting in the targeted
area. The model in column 2 includes the variables avoid_redundant_R&D, R&D_cost_saving,
and time_saving. Two of the three variables are positively
and significantly correlated with project outcomes, suggesting
that the perception of enhanced efficiency from collaboration is
indeed correlated with higher levels of patenting in the targeted
areas. The coefficient on avoid_redundant_R&D is negative.
This result is difficult to interpret without further research,
and is potentially contaminated by its collinearity with R&D_cost_saving.
The model in column 3 measures the association between perceptions
of problems or delays due to collaboration and project outcomes.
As expected, the coefficient on delayed_product_entry is
negative, suggesting that perceptions of delays in getting products
to the marketplace as a result of collaboration are associated
with reduced patenting outcomes. In contrast, the coefficient on delayed_R&D_phase is
positive, suggesting that perceptions of delays in the R&D
phase of a project are associated with increased patenting outcomes.
Although this result is difficult to explain without additional
research, it is possible that technologically ambitious projects
tend to fall behind schedule, but in the end generate greater technological
payoffs.9
Table
4. Consortium-Level Analysis: Qualitative Characteristics of Consortia
Poisson regression
Dependent variable:
Sum of patent grants by consortium participants in the targeted area
| Variables |
(1) |
(2) |
(3) |
| Budget |
-1.39e-07
(5.85e-09) |
-1.58e-07
(8.64e-09) |
-1.27e-07
(5.42e-09) |
| Pre-project
patenting |
.004
(.0000555) |
.005
(.0000555) |
.003
(.0000505) |
| Stimulate
creative thinking |
.382
(.0896) |
|
|
Avoid
redundent R&D
|
|
-.285
(.054) |
|
| R&D
cost savings |
|
2.74e-07
(4.14e-08) |
|
| Time
saving |
|
.428
(.083)
|
|
| Delayed
product entry |
|
|
-.508
(.259) |
| Delayed
R&D phase |
|
|
.747
(.0483 |
| Constant |
2.273
(.1623) |
2.520
(.128) |
2.666
(.0408) |
| R-squared |
.8308 |
.8376 |
.8469 |
Note:
Standard errors in parentheses. The R-squared measure for the Poisson regression
given here is a pseudo-R-squared measure.
IMPLICATIONS
In this section,
we showed that the establishment of an ATP-funded research consortium
stimulates patenting by participating firms in the targeted
technological areas. We identified some characteristics of
consortia that lead to greater relative levels of success. Our
results suggest that technological proximity, as measured by the
degree to which the patenting portfolios of participating firms
are similar, fosters spillovers; this, in turn, enhances the research
productivity of the participating firms in the consortium. We also
find a strong link between pre-consortium patenting in the targeted
area and subsequent success. These results suggest that policy
makers can use technological proximity and pre-consortium patenting
in the targeted area as a criterion for selecting projects and
member firms.10
We established a
statistical link between some of the survey response variables
in the BRS and quantitative outcome measures. The relationship
between total project budgets and total project outcomes is less
clear. The ATP faces a tradeoff between investing relatively large
amounts of money in a small number of projects versus investing
smaller amounts of money in larger numbers of projects. The evidence
we present does not suggest that the projects with the biggest
budgets generate the highest levels of patent output. However,
the measured relationship between budget and outcomes is quite
possibly distorted in our data by the time truncation problem in
our patent data. More research will be necessary to clarify the
nature of this important relationship.
NOTES:
- An alternative
to this measure would be revenues obtained by corporations
from the sales of products whose design and development were
stimulated by participation in consortia. The mapping from
consortia to commercial products, however, is a challenging
task because even the participating firms themselves would
have difficulty tracing the changes in their annual revenues
due to products growing out of their participation in a consortium.
- We acknowledge
with gratitude the superb work done for us on this by the staff
of Bailey Services, Inc.
- However, it
is certainly possible that there may be important technological
complementarities between distant technologies
that this index fails to measure.
- We do not (and cannot)
control for the spillover-stimulating effect of overlapping
consortia. Thus, the estimated spillover effect
attributed to one project may, in fact, partially reflect the spillover
enhancing impact of the overlapping consortia.
- In early 1994,
ATP implemented the Business Reporting System (BRS), an electronically
administered data collection tool for tracking progress of
projects selected for ATP awards from 1993 to the present.
BRS tracks the progress participants are making on their business
plans and projected economic benefits that were originally
outlined in their project proposals and updated over the course
of conducting the research. Data are collected on a routine
and regular basis at the individual participant level within
a project to ensure maximum confidentiality of information.
- We thank Oscar
Jorda of UC-Davis for this suggestion.
- It may be that
the impact on firm patenting observed during the duration of
the project is negligible, such that the estimated coefficient
on project_duration is small. However, after the official
cessation of the project, we may observe a substantial increase
in patenting in the targeted area, as the research results
obtained through the consortia are incorporated in the firms own
research programs.
- Recall in the
Poisson model, the regression coefficients have a semi-elasticity
interpretation. The coefficients represent the percentage change
in firm patenting associated with a unit change in the independent
variable.
- To facilitate
interpretation of the coefficients on the survey response variables,
we restrict our time dimension in these regressions
to observations after the start of an individual project.
- In other regressions
not shown here, we estimated the elasticity of consortium outcomes
with respect to pre-consortium patenting to be approximately
100%.
Date created: January
24, 2003
Last updated:
August 2, 2005
|